Skip to main content

Table 2 Event recording

From: The ALLEGRO trial: a placebo controlled randomised trial of intravenous lidocaine in accelerating gastrointestinal recovery after colorectal surgery

Event

If the event is thought to be an adverse reaction

If the event is not thought to be an adverse reaction

Lidocaine toxicity within 2 h of infusion

Record on adverse event log (SARa if meets criteria for serious)

n/a

Transient events common after surgery (listed in the protocol as: pyrexia; anorexia, nausea, vomiting, constipation, pain; raised inflammatory markers; minor wound infections; dizziness; transient biochemical derangement e.g. hypokalaemia, hyponatraemia, hypomagnesaemia, hypophosphataemia, hypocalcaemia; transient self-limiting confusional state)

Record on adverse event log

Recorded on adverse event log

Complications of surgery Clavien-Dindo grade 1/2

Record on adverse event log

Recorded on adverse event log

Complications of surgery

Clavien-Dindo grade 3+

Record as SAR/SUSAR; report to sponsor within 24 h of becoming aware

Record as outcome data on CRFb

Prolongation of admission for social reasons

n/a

Record as outcome data on CRF

Death

Record as SAR/SUSAR; report to sponsor within 24 h of becoming aware

Record as SAE; report to sponsor within 24 h of becoming aware

  1. aSerious adverse reaction
  2. bCase report form